Identifies themes and clusters of stock movements
Market TodayThemes and Stocks SummaryThematic Stock SearchClick here for daily refresh schedule
RMTI - Rockwell Medical Inc
$1.22
0.00(0.00%)5:00:00 AM 1/14/2021
Rockwell Medical Inc., based in Wixom, Michigan, focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease . The company's primary customers are dialysis providers such as DaVita Inc. .
Stock Chart
No summary

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics
leak data

Related Topics

Peers

Stock news

    01/14/2021RMTI
    Rockwell Medical (RMTI) Looks Good: Stock Adds 5.9% in Session

    Rockwell Medical (RMTI) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

    01/13/2021RMTI
    Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wanbang Biopharmaceuticals, in China

    China is a sizable and growing market, with more than 600,000 patients receiving hemodialysis annuallyWIXOM, Mich., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency anemia management and improving outcomes for patients around the world, today announced that its partner in China, Wanbang Biopharmaceuticals, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Lt...

    01/5/2021RMTI
    Rockwell Medical, Inc. to Present at H.C. Wainwright BioConnect 2021 Conference

    WIXOM, Mich., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency anemia management and improving outcomes for patients around the world, today announced the Rockwell Medical executive management team will record a presentation at H.C. Wainwright BioConnect 2021 Conference. This presentation will become publicly available on January...

    12/16/2020RMTI
    Industry Veteran Andrea Heslin Smiley joins Rockwell Medical’s Board of Directors

    WIXOM, Mich., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency anemia management and improving outcomes for patients around the world, today announced the appointment of industry leader and renowned life science industry executive, Ms. Andrea Heslin Smiley, to its Board of Directors, effective December 11, 2020. Ms. Smiley curren...

    12/2/2020RMTI
    Is Rockwell Medical (NASDAQ:RMTI) Using Debt Sensibly?

    The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

    11/29/2020RMTI
    Where Do Hedge Funds Stand On Rockwell Medical Inc (RMTI)?

    Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in recent weeks. On the other hand, technology hedge funds weren’t timid and registered double digit market beating gains. Financials, energy and industrial stocks aren’t doing […]

    11/9/2020RMTI
    Recap: Rockwell Medical Q3 Earnings

    Shares of Rockwell Medical (NASDAQ:RMTI) fell 2.17% in after-market trading after the company reported Q3 results.Quarterly Results Earnings per share rose 16.67% over the past year to ($0.10), which were in line with the estimate of ($0.10).Revenue of $15,280,000 declined by 0.82% year over year, which missed the estimate of $15,670,000.Looking Ahead Earnings guidance hasn't been issued by the company for now.Rockwell Medical hasn't issued any revenue guidance for the time being.How To Listen T...

    11/9/2020RMTI
    Rockwell Medical, Inc. Provides Third Quarter 2020 Financial and Operational Update

    -Ended the quarter with $67.3 million in cash, cash equivalents and investments- -Q3 2020 revenue of $15.3 million--U.S. commercial launch of Triferic® AVNU expected in Q1 2021--Poised to enroll first patient in Phase 3 clinical trial of Triferic in China--Unveiled plans to develop FPC platform in new indications-WIXOM, Mich., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the t...